|
Workshop
[Free Online Workshop] Career Transition for Research Scientists: Business Development & BioPartnering
Speakers:
Lesley Stolz (J&J), Jimmy Zhang (previously Merck, J&J, Lilly), Cheni Kwok (Linear Dreams), Sarah Bodary (Darwin Bodary Consulting), Lizabeth Leveille (Merck), Jennifer Leeds (Retired from Novartis)
Organizers:
Toby Freedman (Synapsis Search Biotech Recruiting), Rachel Kindt (Rachel Kindt Consulting), Sandra Morris (MorTil Consulting), Dean Wilson (PBSS)
Date:
2024-11-13
Time:
8:30-12:30 Pacific Time
Registration fee:
Free
Location:
Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2024-11-12
(it will close sooner if the seating cap is reached)
About the Topic
Evolving career landscapes and interests can lead beyond the typical vertical climb through a given specialty in R&D. Fortunately, there are many paths potentially available for scientists seeking roles beyond the bench.
In this second PBSS workshop of a series, career transitions to Business Development (BD) / BioPartnering will be explored. Experienced experts from startup, biotech, and pharma companies, spanning both “sell” and “buy” sides, will describe the BD career path and provide advice, including:
- The landscape of BD roles and responsibilities; status and trends
- Differences between large and small companies
- Paths to entering the field
- Desirable attributes of those considering BD roles (what hiring managers might look for)
- Lessons learned from careers in BD
- Traits that might suggest avoiding the BD path
- Pros and cons of the career
- Personal advice and experiences
Each presentation will include brief Q&A, and the workshop will conclude with a panel discussion.
Subsequent workshops in the series will explore career transitions into Clinical Development, Clinical Operations, Commercial, Venture Capital, Medical Affairs, Intellectual Property, and others.
An additional 1-day, in-person PBSS workshop on BD and BioPartnering is scheduled for February 26, 2025, presented by BD subject matter experts. Please continue to watch PBSS postings for details.
Time (PT) |
Topic |
Speaker
|
8:30-8:40 am |
PBSS Welcome |
Dean Wilson, PhD, PBSS |
8:40-9:15 am |
Business Development Overview |
Lesley Stolz, PhD, VP, Early Innovation Partnering, Johnson & Johnson Innovation |
9:15-9:40 am |
Panelist Presentation |
Jimmy Zhang, PhD, MBA, Biotech BD Executive, previously at Merck, J&J, Lilly Asia Ventures |
9:40-10:05 am |
Panelist Presentation |
Cheni Kwok Ph.D. CLP, Managing Partner & Founder, Linear Dreams LLC |
10:05-10:30 am |
Panelist Presentation |
Sarah Bodary, PhD, Biotech Advisor/Investor, Darwin Bodary Consulting |
10:30-10:45 am |
Break |
|
10:45-11:10 am |
Panelist Presentation |
Lizabeth Leveille, MS, MBA, VP, BD&L; Head, Boston & European Innovation Hubs & Discovery Transactions, Merck & Co. Inc. |
11:10-11:35 pm |
Panelist Presentation |
Lesley Stolz, PhD, VP, Early Innovation Partnering, Johnson & Johnson Innovation |
11:35-12:00 pm |
Panelist Presentation |
Jennifer Leeds, PhD, Retired from Novartis BD as Head of Search and Evaluation, West Coast and Canada |
12:00-12:30 pm |
Panel Discussion |
All Speakers (Moderators : Dean and Rachel) |
2024-11-15, [In-Person] Current State of Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapies
|
2024-12-05, [Free Online] Innovative Mass Spectrometry and Related Technologies for Life Science and Drug Development
|
2024-12-13, Why All These New Modalities?
|
2025-01-22, [In-Person] Small-Molecule Formulation for Discovery & Early Development (jointly by PBSS / AAPS-BADG / Syner-G)
|
2025-02-06, [In-Person] Intellectual Property (IP) Strategies and Best Practices
|
2025-02-26, [In-Person] Demystifying Biopharma Business Development
|
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
|
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
Aroga Biosciences
Aroga Biosciences is an award-winning CRO specializing in scientific writing for nonclinical reports, INDs, CMC, and clinical documents.
|
Allucent
Bringing innovation to Biotech w/ClinPharm Modeling & Simulation services to inform dose, design, modeling + development strategies.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
PharmaResources
Top-tier small molecule CRO/CDMO offering comprehensive supports from Medicinal Chemistry, DMPK, and CMC to GMP manufacturing for commercialization.
|
Aliri Bioanalysis
to the rescue! Pioneers in LCMS & Oligo bioanalysis w/ 30+ years of experience putting dev. programs back on track with quality data & fast timelines.
|
Submit a Text Ad
|